Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Gennex Laboratories Ltd Performance

Today's Low
14.20
arrowIcon
Today's High
14.98
52 Wk Low
6.12
arrowIcon
52 Wk High
21.89


Open

14.75

Traded Value (Cr)

53.10 L

Prev. Close

14.65

VWAP

14.7

Volume

3,70,279

Face Value

1

Gennex Laboratories Ltd Fundamentals

Market Cap
₹ 321 Cr
P/E Ratio (TTM)
30.04
P/B Ratio
2.01
Debt to Equity
0.25
ROE
10.43 %
EPS (TTM)
0.47
Dividend Yield
0.00%
Book Value
7.04

Click here to know more about Fundamentals

Gennex Laboratories Ltd Financials

Gennex Laboratories Ltd Financials

Gennex Laboratories Ltd Shareholding Pattern

Held By Mar 2024 Feb 2024 Dec 2023 Sep 2023
Retail 60.42 % 58.81 % 60.22 % 58.05 %
Others 21.16 % 22.78 % 16.18 % 18.34 %
Promoters 18.42 % 18.42 % 23.60 % 23.60 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

60.42%

Others

21.16%

Promoters

18.42%

FII

0.00%

Mutual Funds

0.00%

Retail

58.81%

Others

22.78%

Promoters

18.42%

FII

0.00%

Mutual Funds

0.00%

Retail

60.22%

Others

16.18%

Promoters

23.60%

FII

0.00%

Mutual Funds

0.00%

Retail

58.05%

Others

18.34%

Promoters

23.60%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹14.45

PIVOT

resistance-arrow
Resistance
First Resistance₹15.007
Second Resistance₹15.893
Third Resistance₹16.447
support-arrow
Support
First Resistance₹13.567
Second Resistance₹13.013
Third Resistance₹12.127
RSI24.300
MACD-0.863
ADX14.941
CCI-164.942

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day394,276294,71579.59
Week503,149407,31580.91
1 Month544,662410,74576.47
6 Months000.00

About Gennex Laboratories Ltd

Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985. The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal. The company thrives on the strength of its exports to various countries viz. Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others. The Company's factory is situated at Andhra Pradesh, India. The company has a professionally managed team at every stage of its operations. During the year 2005-2006, the company implemented GMP (Good Manufacturing Practices). In 2006-07, it installed Separate Air Handling System in final drug isolation area and also in drying and packing area. Also, it implemented the CGMP in manufacturing area as per ICH & WHO Guidelines. In 2007-2008, it diversified into the business of Biotech product. The Company acquired 51% shareholding in Deccan Remedies Limited and thus became the subsidiary of the Company in 2023.

Managing Director

Arihant Baid

Founded

1990

NSE Symbol

Gennex Laboratories Ltd Management

NameDesignation
Y Ravinder ReddyIndependent Director
Arihant BaidChairman & Managing Director
T M GopalaKrishnanWhole-time Director
Sadhana BhansaliIndependent Director
A S Nageswar RaoIndependent Director
A Ranga Rao PantuluIndependent Director

Gennex Laboratories Ltd News

Gennex Laboratories to hold board meeting
On 14 February 2024
Gennex Laboratories EGM scheduled
On 30 December 2023
Gennex Laboratories to hold board meeting
On 2 December 2023
Gennex Laboratories consolidated net profit rises 192.38% in the September 2023 quarter
Sales decline 8.01% to Rs 17.58 crore
Gennex Laboratories schedules board meeting
On 14 November 2023
Gennex Laboratories AGM scheduled
On 30 September 2023
Gennex Laboratories to CONDUCT BOARD MEETING
On 6 September 2023
Gennex Laboratories consolidated net profit rises 280.00% in the June 2023 quarter
Sales rise 18.29% to Rs 16.49 crore
Gennex Laboratories standalone net profit rises 242.67% in the June 2023 quarter
Sales rise 1.43% to Rs 14.14 crore
Gennex Laboratories to discuss results
On 14 August 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,493.35
(-1.85 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,358.80
(-1.88 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,789.50
(-3.55 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,879.05
(-2.93 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 967.80
(-3.77 %)
36.23

Gennex Laboratories Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Gennex Laboratories Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Gennex Laboratories Ltd's share price is ₹14.34 as of May 9, 2024

Gennex Laboratories Ltd's P/E ratio is 30.04 times as of May 9, 2024.

Gennex Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 2.01, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Gennex Laboratories Ltd's market is 321 Cr as on May 9, 2024.

The current financial records of Gennex Laboratories Ltd show a 10.43% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Gennex Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Gennex Laboratories Ltd's 52-week high and low as of May 9, 2024 are ₹14.98 and ₹14.2 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Gennex Laboratories Ltd stands at 18.42%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.